IN2014DN07091A - - Google Patents

Info

Publication number
IN2014DN07091A
IN2014DN07091A IN7091DEN2014A IN2014DN07091A IN 2014DN07091 A IN2014DN07091 A IN 2014DN07091A IN 7091DEN2014 A IN7091DEN2014 A IN 7091DEN2014A IN 2014DN07091 A IN2014DN07091 A IN 2014DN07091A
Authority
IN
India
Prior art keywords
sodium
hydroxysafflor yellow
hydroxysafflor
yellow
safflower
Prior art date
Application number
Other languages
English (en)
Inventor
Fengqi Ye
Ben Cai
Min Lu
Yongling Chen
Original Assignee
Zhejiang Yongning Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Yongning Pharmaceutical Co Ltd filed Critical Zhejiang Yongning Pharmaceutical Co Ltd
Publication of IN2014DN07091A publication Critical patent/IN2014DN07091A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IN7091DEN2014 2013-02-07 2013-06-08 IN2014DN07091A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310048476.8A CN103980239B (zh) 2013-02-07 2013-02-07 羟基红花黄色素a钠及其生产方法和用途
PCT/CN2013/000686 WO2014121424A1 (zh) 2013-02-07 2013-06-08 羟基红花黄色素a钠及其生产方法和制药用途

Publications (1)

Publication Number Publication Date
IN2014DN07091A true IN2014DN07091A (ja) 2015-04-24

Family

ID=51272434

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7091DEN2014 IN2014DN07091A (ja) 2013-02-07 2013-06-08

Country Status (7)

Country Link
US (1) US9243019B2 (ja)
EP (1) EP2829547B1 (ja)
JP (1) JP6133415B2 (ja)
KR (1) KR101801700B1 (ja)
CN (2) CN103980239B (ja)
IN (1) IN2014DN07091A (ja)
WO (1) WO2014121424A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104230864A (zh) * 2013-06-08 2014-12-24 浙江永宁药业股份有限公司 新的羟基红花黄色素a二价药用盐及其制备方法和用途
IN2014DN10592A (ja) * 2013-02-07 2015-09-11 Zhejiang Yongning Pharmaceutical Co Ltd
CN103980239B (zh) * 2013-02-07 2016-04-13 浙江永宁药业股份有限公司 羟基红花黄色素a钠及其生产方法和用途
CN105901923B (zh) * 2016-06-03 2017-10-24 佛山市迪赛纳科技有限公司 升降机构及包含升降机构的升降工作台和工作台升降方法
CN106214719B (zh) * 2016-08-31 2020-01-24 江西桔王药业有限公司 一种舒胸颗粒的制备方法
CN108392486B (zh) * 2018-01-23 2020-01-03 滨州医学院 羟基红花黄色素b在制备防治心肌缺血再灌注损伤的药物中的应用
CN113504199A (zh) * 2021-06-29 2021-10-15 苏州泽达兴邦医药科技有限公司 一种基于数据挖掘的红花提取液树脂纯化过程质量控制方法
CN113816933B (zh) * 2021-10-14 2024-02-09 北京悦康科创医药科技股份有限公司 一种羟基红花黄色素a的制备方法
CN113995729B (zh) * 2021-10-22 2022-11-18 北京悦康科创医药科技股份有限公司 羟基红花黄色素a口服半固体胶囊及其制备方法和应用
CN114098074A (zh) * 2021-11-09 2022-03-01 江南大学 羟基红花黄色素a在增强耐力中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4510230B2 (ja) * 2000-05-26 2010-07-21 三栄源エフ・エフ・アイ株式会社 脱臭ベニバナ黄色素
CN1284794C (zh) 2002-08-17 2006-11-15 李盛学 羟基红花黄色素a的制备方法
CN100418522C (zh) * 2004-01-08 2008-09-17 山东瑞阳制药有限公司 大剂量的羟基红花黄色素a或其可药用盐的制药应用
JP2007063130A (ja) * 2004-03-31 2007-03-15 Kureha Corp 抗糖尿病用組成物
CN1935176B (zh) * 2005-09-23 2010-07-14 北京星昊医药股份有限公司 含有总红花黄色素的红花提取物的制备方法
CN100427107C (zh) * 2006-06-24 2008-10-22 太原华卫药业有限公司 一种红花注射液制备方法
CN101195647B (zh) 2006-12-06 2010-08-18 山西华辉凯德制药有限公司 羟基红花黄色素a及其制备方法和应用
CN101879155B (zh) * 2007-12-04 2011-12-21 哈药集团中药二厂 注射用丹红的制备方法
CN101168539B (zh) * 2007-12-04 2011-01-19 哈药集团中药二厂 丹酚酸b的提取方法
CN101215307B (zh) 2008-01-08 2010-11-10 山西大学 一种羟基红花黄色素a的制备方法
CN101640392A (zh) * 2009-07-15 2010-02-03 武汉科瑞德电力科技有限公司 35kV配电线路带电作业断引流线的作业方法
CN102675379B (zh) 2011-03-15 2015-08-19 河北以岭医药研究院有限公司 一种从红花中提取精制羟基红花黄色素a的方法
CN102702150B (zh) * 2012-06-19 2014-09-17 浙江永宁药业股份有限公司 一种羟基红花黄色素a的制备方法和应用
CN103980239B (zh) * 2013-02-07 2016-04-13 浙江永宁药业股份有限公司 羟基红花黄色素a钠及其生产方法和用途

Also Published As

Publication number Publication date
CN104603143B (zh) 2016-12-14
EP2829547A1 (en) 2015-01-28
CN103980239A (zh) 2014-08-13
WO2014121424A1 (zh) 2014-08-14
JP6133415B2 (ja) 2017-05-24
JP2015525232A (ja) 2015-09-03
CN104603143A (zh) 2015-05-06
EP2829547A4 (en) 2015-11-18
US9243019B2 (en) 2016-01-26
CN103980239B (zh) 2016-04-13
US20150025030A1 (en) 2015-01-22
KR20150035491A (ko) 2015-04-06
EP2829547B1 (en) 2018-04-04
KR101801700B1 (ko) 2017-11-27

Similar Documents

Publication Publication Date Title
IN2014DN07091A (ja)
EA201590251A1 (ru) Новые 5-аминотетрагидрохинолин-2-карбоновые кислоты и их применение
IL257963B (en) Compounds for the treatment of diseases related to the production of mitochondrial reactive oxygen species (ros).
EA201690069A1 (ru) Применение высоких доз придопидина для лечения болезни хантингтона
EA201391029A1 (ru) Производные оксазина и их применение при лечении неврологических нарушений
EA201291348A1 (ru) Активаторы растворимой гуанилатциклазы
AR109679A1 (es) Sales de adición de ácidos de un derivado de benzimidazol ((s)-4-(5,7-difluorocroman-4-iloxi)-n,n,2-trimetil-1h-benzo[d]imidazol-6-carboxamida)
EA201491854A1 (ru) Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств
MX355330B (es) Formas cristalinas de compuestos terapeuticos y sus usos.
MY176246A (en) Compositions for oral administration of zoledronic acid or related compounds for treating disease
EA201600096A1 (ru) Бензил-1н-пиразол[3,4-b]пиридины и их применение
RU2019110980A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral
EP3285771A4 (en) Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
HRP20201187T1 (hr) Derivat triazolopirazinona koristan kao inhibitor ljudskog pde1
MX357888B (es) Sales basicas de adicion de nitroxolina y usos de las mismas.
EP3256208A4 (en) Monitoring of intrinsic heart rate recovery to improve stimulation therapy for heart failure patients
EA201591704A1 (ru) Новые устойчивые соли пентадекапептида, способ их получения, их применение в производстве фармацевтических составов и их применение в терапии
MX2017015202A (es) Formulaciones liquidas de celecoxib para administracion oral.
UA109359C2 (xx) Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном
WO2015031198A3 (en) Bendamustine pharmaceutical compositions
MX2015007885A (es) Compuestos farmaceuticos.
IN2014DN10592A (ja)
MX2015004577A (es) Suplemento nutricional para pacientes con enfermedades reumaticas.
MX2017012110A (es) Forma cristalina de ahu377, metodo de preparacion y uso de la misma.